Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	593	431	260	46	71	46
Market Cap Growth	46.80%	65.92%	464.37%	-35.49%	56.49%	-0.03%
Enterprise Value	579	421	215	32	54	28
Last Close Price	0.29	0.24	0.32	0.34	0.69	1.04
PB Ratio	6.56	3.86	5.86	8.60	2.52	2.32
P/TBV Ratio	42.04	3.86	5.86	8.60	2.52	2.32
Quick Ratio	8.82	9.78	5.42	1.50	9.16	10.88
Current Ratio	9.52	10.34	5.84	1.76	9.28	11.06
Return on Equity (ROE)	-75.52%	-73.94%	-177.51%	-188.41%	-113.20%	-108.08%
Return on Assets (ROA)	-44.98%	-41.82%	-85.39%	-90.05%	-63.81%	-61.53%
Return on Capital Employed (ROCE)	-96.30%	-53.10%	-101.40%	-593.50%	-96.10%	-89.30%
Earnings Yield	-14.19%	-13.38%	-16.98%	-68.93%	-38.05%	-38.44%
FCF Yield	-	-13.65%	-17.40%	-64.50%	-36.22%	-35.71%
Buyback Yield / Dilution	-126.82%	-105.97%	-336.53%	-89.21%	-124.32%	-187.81%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.